Alembic Pharma informs about press release

26 Dec 2017 Evaluate

Alembic Pharma has informed about press release announcing that the USFDA has granted Orphan-Drug Designation for Tenalisib (RP6530).

The above information is a part of company’s filings submitted to BSE.

Alembic Pharma Share Price

1038.20 -4.40 (-0.42%)
21-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1777.65
Dr. Reddys Lab 1194.55
Cipla 1465.65
Lupin 2043.30
Zydus Lifesciences 944.25
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.